Literature DB >> 35754707

Eucommia ulmoides Olive Male Flower Extracts Ameliorate Alzheimer's Disease-Like Pathology in Zebrafish via Regulating Autophagy, Acetylcholinesterase, and the Dopamine Transporter.

Chen Sun1,2, Shanshan Zhang1,2, Shuaikang Ba1,2, Jiao Dang1,2, Qingyu Ren1,2, Yongqiang Zhu1,2, Kechun Liu1,2, Meng Jin1,2.   

Abstract

Alzheimer's disease (AD) is the most prevalent neural disorder. However, the therapeutic agents for AD are limited. Eucommia ulmoides Olive (EUO) is widely used as a traditional Chinese herb to treat various neurodegenerative disorders. Therefore, we investigated whether the extracts of EUO male flower (EUMF) have therapeutic effects against AD. We focused on the flavonoids of EUMF and identified the composition using a targeted HPLC-MS analysis. As a result, 125 flavonoids and flavanols, 32 flavanones, 22 isoflavonoids, 11 chalcones and dihydrochalcones, and 17 anthocyanins were identified. Then, the anti-AD effects of the EUMF were tested by using zebrafish AD model. The behavioral changes were detected by automated video-tracking system. Aβ deposition was assayed by thioflavin S staining. Ache activity and cell apoptosis in zebrafish were tested by, Acetylcholine Assay Kit and TUNEL assay, respectively. The results showed that EUMF significantly rescued the dyskinesia of zebrafish and inhibited Aβ deposition, Ache activity, and occurrence of cell apoptosis in the head of zebrafish induced by AlCl3. We also investigated the mechanism underlying anti-AD effects of EUMF by RT-qPCR and found that EUMF ameliorated AD-like symptoms possibly through inhibiting excessive autophagy and the abnormal expressions of ache and slc6a3 genes. In summary, our findings suggested EUMF can be a therapeutic candidate for AD treatment.
Copyright © 2022 Sun, Zhang, Ba, Dang, Ren, Zhu, Liu and Jin.

Entities:  

Keywords:  AD; Ache; AlCl3; flavonoids; slc6a3

Year:  2022        PMID: 35754707      PMCID: PMC9222337          DOI: 10.3389/fnmol.2022.901953

Source DB:  PubMed          Journal:  Front Mol Neurosci        ISSN: 1662-5099            Impact factor:   6.261


Introduction

Alzheimer’s disease (AD) is a common neurodegenerative disease which is age-related. Patients with AD are characterized by the progressive loss of acquired knowledge and memory decline. The loss of neurons, formation of neurofibrillary tangles, tau protein aggregation, amyloid β-protein (Aβ) deposition, and low levels of acetylcholine (ACh) are the main clinical hallmarks of AD (Kepp, 2016; Sanabria-Castro et al., 2017). The aging tendency of the population is leading to an increased prevalence of AD. Currently, over 47 million people have been diagnosed with AD, and this has caused heavy burdens for families and society (Neves et al., 2021). To deal with this situation, many AD drugs have been developed, such as anti-tau, an amyloid β-protein (Aβ) aggregation inhibitor, and cholinergic-enhancing and anti-inflammatory drugs. Unfortunately, these drugs are not able to prevent the progression of AD and only can improve cognitive function and memory to a certain extent (Pearson, 2001; Huang and Mucke, 2012). Therefore, the development of AD drugs is an urgent task. Because of their novel structures and extensive physiological activities, natural products from plants have been always an important source of drug development. Eucommia ulmoides Olive (EUO), also named Du-zhong, is a deciduous tree in the family of Eucommiaceae (Yan et al., 2018). It is also the traditional Chinese herb. The leaf and bark of EUO are officially documented in the Chinese Pharmacopeia. The leaf extracts of EUO are reported to be treat AD, aging, diabetes, hypertension, and osteoporosis (He et al., 2014). However, studies investigating the male flowers of EUO began relatively late. Currently, many studies have shown that the male flowers, like the leaf and bark of EUO, also contain many bioactive components including lignans, megastigmane glycosides, iridoids, phenolics, and flavonoids. These bioactive constituents have typically exhibited neuroprotective, anti-oxidant, anti-tumor, anti-inflammatory, anti-hypertensive, anti-aging, immunity promotion, and other activities (Luo et al., 2010; Kobayashi et al., 2012; Zhang et al., 2012; Niu et al., 2015; Hao et al., 2016; Yan et al., 2018). There are similar bioactive constituents between the male flower and leaf of EUO. Hence, we hypothesize that extracts of the EUO male flower (hereafter referred to as EUMF) may have anti-AD activity. Zebrafish is an ideal model system for human disease and drug development. They possess a high homology to humans and have rapid development and small sizes (Kerstin et al., 2013; Hong et al., 2020). Many studies have reported that a zebrafish AD model can be established by using AlCl3, an in vivo animal model that can mirror the primary characteristic pathological changes of patients with AD. Various clinical hallmarks of AD can be detected in this model (Huang et al., 2016; Pan et al., 2019). But unfortunately, an important clinical hallmark-Aβ deposition has not yet been successfully detected in zebrafish AD model. In summary, in this study we isolated and purified the EUMF and identified the chemical compositions. To verify our hypothesis mentioned in the previous paragraph, the zebrafish AD model was used to investigate the therapeutic effect of EUMF on AD symptoms. In addition, Aβ deposition detection was used innovatively in our zebrafish AD model. Finally, we further tested the mRNA expressions of key factors involved in autophagy and the regulation of neurotransmitters to reveal the underlying mechanism.

Materials and Methods

Animals

The adult wild-type zebrafish (AB strain) were maintained in a zebrafish facility at 28.5°C ± 0.5°C with a 14 h light/10 h dark cycle photoperiod at the Key Laboratory for Drug Screening Technology of the Shandong Academy of Sciences. Larvae were obtained from natural mating. Zebrafish larvae at 3 days post-fertilization (dpf) were used this study. All experiments were conducted in compliance with the standard ethical guidelines and under the control of the Biology Institute, the Qilu University of Technology of Animal Ethics Committee.

Preparation of the Eucommia ulmoides Olive Male Flower

The hydrothermal extraction method is used to prepare EUMF. Approximately 20 g of dried EUMF powder was placed into a flask, and 2,000 mL of ultrapure water was added. Then the flask was placed into an electric jacket for extraction by heat reflux three times, 2 h each time. The supernatant was obtained by centrifugation at 5,000 rpm for 10 min. The combined extraction solution was concentrated by rotary evaporation and then freeze-dried to obtain the EUMF.

Identification of Flavonoid Compounds Using HPLC-MS

A targeted HPLC-MS analysis of the flavonoid compounds was performed on SCIEX Qtrap 6500 + system (SCIEX, United States). The Xselect HSS T3 C18 column (2.1 × 150 mm, 2.5 μm) was used for sample separation. Distilled water containing 0.1% formic acid was used as solvent A, and acetonitrile containing 0.1% formic acid was used as solvent B. The elution condition was maintained at 2% B for 2 min, from 2 to 100% B for 13 min, maintained at 100% B for 2 min, and equilibrated with the initial elution solvent for 3 min. The flow rate was 0.4 mL/min. The injection volume of the sample was 1 μL. The column temperature was set to be 50°C. Mass spectrometry was performed in both the positive and negative ion modes. The optimal positive MS parameters were a curtain gas pressure of 35 psig and an ion spray voltage of 5,500 V at a temperature of 550°C. For the negative MS mode, the ion spray voltage was set as −4,500 V and the other parameter was the same as the positive mode. All of the compounds were identified according to LC and MS information and compared with flavonoid compound databases that were supplied by the Novogene Co., Ltd. (Tianjin, China).

Establishment of Zebrafish Alzheimer’s Disease Model

The establishment of the zebrafish AD model referenced to the previous studies (Huang et al., 2016; Pan et al., 2019) with a slight modification. In brief, 3 dpf larval zebrafish were randomly transferred to six-well cell culture plates with a density of approximately 20 larvae per well. Then they were treated with 80 μM AlCl3 from 3 to 6 dpf to generate the zebrafish AD models.

Eucommia ulmoides Olive Male Flower and Donepezil Treatments

The larvae were treated with different concentrations of EUMF (100, 200, 300, 400, 500, 600, 700, 800, and 1,600 μg/mL) from 3 to 6 dpf. We found that the LC1 and LC50 of the EUMF were 206 and 454 μg/mL, respectively, based on the EUMF lethality curve of Figure 1A. LC1 is typically regarded as a no-observed-effect concentration value. Therefore, we tested the anti-AD activity of the EUMF at concentrations below LC1 (206 μg/mL). The zebrafish larvae were co-treated with 80 μM AlCl3 and EUMF at three different concentrations (50, 100, and 200 μg/mL) from 3 to 6 dpf (Figure 1B). Donepezil which is the inhibitor of acetylcholinesterase (Ache) was used as the positive drug. In the positive group, the larvae were co-treated with 80 μM AlCl3 and 4.0 μM donepezil from 3 to 6 dpf. After treatment, 10 larvae from each group were randomly selected for the image acquisition.
FIGURE 1

Mortality curve and experimental workflow chart. (A) Larval zebrafish were exposed to different concentrations of EUMF (100, 200, 300, 400, 500, 600, 700, 800, and 1,600 μg/mL) from 3 to 6 dpf. The mortality was recorded within each group at 3, 4, 5, and 6 dpf. Dead larvae were judged using missing heartbeats. (B) Larvae at 3 dpf were co-exposed to AlCl3 and three different concentrations of EUMF from 3 to 6 dpf. At 6 dpf the zebrafish were subjected to a behavioral test. In addition, we also evaluated the AchE activity, Aβ deposition, and apoptosis in the brain and performed RT-qPCR.

Mortality curve and experimental workflow chart. (A) Larval zebrafish were exposed to different concentrations of EUMF (100, 200, 300, 400, 500, 600, 700, 800, and 1,600 μg/mL) from 3 to 6 dpf. The mortality was recorded within each group at 3, 4, 5, and 6 dpf. Dead larvae were judged using missing heartbeats. (B) Larvae at 3 dpf were co-exposed to AlCl3 and three different concentrations of EUMF from 3 to 6 dpf. At 6 dpf the zebrafish were subjected to a behavioral test. In addition, we also evaluated the AchE activity, Aβ deposition, and apoptosis in the brain and performed RT-qPCR.

Behavioral Analysis

The larvae from each group were randomly collected, and cleaned using an embryo medium (1 mM MgSO4, 0.5 mM KCl, 15 mM NaCl, 0.05 mM (NH4)3PO4, 0.15 mM KH2PO4, 0.7 mM NaHCO3, and 1 mM CaCl2). They were then placed in 48-well plates. After a 20-min acclimation period, the locomotor activity for each larva was recorded using an automated computerized video-tracking system (Viewpoint, Lyon, France). The behavioral tests contained three alternating light-dark cycles with 60 min (10 min illumination, 10 min darkness alternately). Zeblab software (Viewpoint, Lyon, France) was used to recorded and analyzed the zebrafish movement distance and speed change to light-dark and dark-light cycles.

Detection of the Amyloid β-Protein Deposition

The zebrafish larvae were fixed using 4% paraformaldehyde. All of the fixed zebrafish were processed by embedding in the optimal cutting temperature compound (OCT Compound, SAKURA, United States) and frozen at −20°C until sectioning. Subsequently, the tissue sections were used for thioflavin S staining (Chao et al., 2018). In brief, the sections were washed with 0.01 M phosphate buffered solution (PBS) for 30 min at room temperature. Next, 0.3% thioflavin S (Sigma-Aldrich, Darmstadt, Germany) was introduced, and the sections were incubated for 8 min at room temperature in the dark. Finally, the sections were washed with 0.01 M PBS for 30 min in dark, and a fluorescence microscope (Zeiss, Jena, Germany) was used to analyze the sections. The fluorescence intensity of the Aβ deposition in the head was measured using Image-Pro Plus version 5.1.

Determination of Ache Activity

After co-treatment with AlCl3 and EUMF, zebrafish larvae at 6 dpf were killed by tricaine (Sigma-Aldrich, Darmstadt, Germany). Cold physiological saline was added to the larvae in a 2 mL tube at a ratio of 1:9 (mass:volume) without any additional water. Next, the samples were homogenized using automated tissue homogenization, followed by centrifuged at 2,500 rpm for 10 min at 0°C. The supernatant was collected for the assay. The enzyme activity of Ache was determined by using the Amplite™ Fluorimetric Acetylcholinesterase Assay Kit (AAT Bioquest, California, United States) according to the manufacturer’s instructions with a slight modification as follows. The acetylthiocholine reaction mixture was 50 μM. The test samples addition added into the acetylthiocholine reaction mixture was also 50 μM. The fluorescence at Ex/Em = 490/520 was monitored.

Apoptosis Assessment

Apoptotic cells in the head were assessed using the One Step TUNEL Apoptosis Assay Kit (Beyotime, Jiangsu, China). Briefly, the zebrafish larvae at 6 dpf were fixed in 4% paraformaldehyde. Next, they were blocked with 3% hydrogen peroxide in methanol and incubated with the TUNEL reaction mixture. The larvae were photographed by using a fluorescence microscope (Zeiss, Jena, Germany). The fluorescence intensities of apoptotic cells in the head were measured using Image-Pro Plus version 5.1.

Detection of Gene Expression

The expression of six genes: autophagy and beclin 1 regulator 1a (ambra1a), autophagy-related gene 5 (atg5), unc-51 like autophagy activating kinase 1 (ulk1b), autophagy-related ubiquitin-like modifier LC3 B (lc3b), acetylcholinesterase (ache), and solute carrier family 6 member 3 (slc6a3) were detected in the zebrafish larvae using RT-qPCR. The total RNA was extracted from the larval tissue using the EASY spin Plus RNA Mini Kit (Aidlab Biotechnologies, Beijing, China) according to manufacturer instructions. Next, RNA was reverse transcribed into cDNA using the PrimeScript™ RT Master Mix (Takara Biomedical Technology Co., Ltd., Beijing, China), The RT-qPCR was conducted using the SYBR® Premix DimerEraser™ (Takara Biomedical Technology Co., Ltd., Beijing, China). The housekeeping gene, rpl13a, was used as a reference gene. The primer sequences of the above genes are shown in Table 1.
TABLE 1

The sequences of primer pairs used in real-time quantitative PCR assay.

NoGene symbolForward primerReverse primer
1 ambra1a TAACCAGGAAACTGGCCAACAATATGCTGCAGGGGACAAC
2 atg5 AGGGGATAACAGCACAAACGCTTCTTATGCAGCGTGTCCA
3 ulk1b AGGCCGAAAGTCTCACTTCAAGCCATGTACATCGGAGACC
4 lc3b CCTCCAACTCAACTCCAACCGCCGTCTTCGTCTCTTTCC
5 ache TCTTGCCCACTGTGCTACTCTCTTGTACCCTGCACTCTGC
6 slc6a3 CTAATCGCCTTCTCCAGCTACAGGCCACGTTGTGTTTCTGTGACAT
7 rpl13a TCTGGAGGACTGTAAGAGGTATGCAGACGCACAATCTTGAGAGCAG
The sequences of primer pairs used in real-time quantitative PCR assay.

Statistical Analysis

The data are presented as mean ± SEM. The statistical analyses were conducted using Graph Pad Prism 8.0 (GraphPad Software; San Diego, CA, United States) by a one-way ANOVA followed by the Dunnett’s multiple comparison test. If the P-value was less than 0.05, the difference was considered as significant.

Results

Flavonoids Compounds Analysis of the Eucommia ulmoides Olive Male Flower

A large number of literature studies have shown that flavonoids show neuroprotective effects against AD (Remya et al., 2012; Remya et al., 2014; Bakhtiari et al., 2017; Zhao et al., 2019; Li et al., 2021; Noori et al., 2021; Pragya and Arun, 2021). Thus, the flavonoids were selected as the primary components of EUMF for further study. The total contents of the EUMF flavonoids were determined according to the obtained standard curves of the total flavonoids which was reported in a previous study from our lab (Zhang et al., 2020). According to regression equations (y = 0.0003x + 0.0107), the total contents of the EUMF flavonoids were 45.99 ± 0.5853 mg/g. Moreover, the targeted LC-MS analysis of the flavonoids showed that total 206 compounds were detected (Table 2). Among them, 125 flavonoids and flavanols, 32 flavanones, 22 isoflavonoids, 11 chalcones and dihydrochalcones, and 17 anthocyanins were identified. In addition, quercetin-3′-O-glucoside (relative content of 9.1850%), isoquercitrin (8.8025%), rutin hydrate (8.0753%), rutin (7.9072%), spiraeoside (7.5218%), isotrifoliin (7.3683%), isorhamnetin-3-O-neohespeidoside (6.5757%), naringenin (5.7225%), naringenin chalcone (5.6733%), butin, myricitrin, isomucronulatol-7-O-glucoside, hyperoside, hesperetin 5-O-glucoside, narcissoside, di-O-methylquercetin, lonicerin and morin were the primary components of EUMF. The relative content of these 18 components accounted for greater than 90% of the total flavonoids.
TABLE 2

Flavonoids compounds identified in EUMF by LC-MS.

NoRT (min)Molecular WeightFormulaNameRelative content (%)Class
10.680274.084C15H14O5Afzelechin0.0854Flavonoids
20.700420.454C25H24O6Kuwanon A0.0064Flavones and Flavanols
30.710448.400C22H22O11Methylluteolin C-hexoside0.0210Flavones and Flavanols
40.720418.100C21H22O9O-methylnaringenin C-pentoside0.2106Flavanones
50.720418.394C21H22O9Methylnaringenin C-pentoside0.2024Flavanones
60.730402.350C20H18O9Apigenin C-pentoside0.0411Flavones and Flavanols
70.730446.404C22H22O10Methylapigenin C-hexoside0.0837Flavones and Flavanols
80.730550.460C25H26O14di-C, C-pentosyl-luteolin0.0554Flavones and Flavanols
90.740478.400C22H22O12Selgin C-hexoside0.0150Flavones and Flavanols
100.780342.343C19H18O6Methylophiopogonanone A0.0025Isoflavonoids
110.940478.400C22H22O12Selgin 5-O-hexoside0.0348Flavones and Flavanols
120.950272.069C15H12O5Butein0.0093Chalcones and dihydrochalcones
130.970476.430C23H24O11Irisolidone 7-O-beta-d-glucoside0.0106Isoflavonoids
140.970476.430C23H24O11Methylchrysoeriol 5-O-hexoside0.0136Flavones and Flavanols
150.970508.430C23H24O13Limocitrin O-hexoside0.0236Flavones and Flavanols
160.980756.660C33H40O20C-hexosyl-apigenin O-hexosyl-O-hexoside0.0048Flavones and Flavanols
170.980479.000C22H23O12Petunidin 3-O-glucoside0.0489Anthocyanins
181.000624.552C28H32O16C-hexosyl-chrysoeriol O-hexoside0.0105Flavones and Flavanols
191.010286.279C16H14O5Sakuranetin0.0118Flavanones
201.010416.378C21H20O9Methylapigenin C-pentoside0.0043Flavones and Flavanols
211.040430.405C22H22O9Ononin0.0468Isoflavonoids
221.130868.702C43H32O208-Gingerol0.0069Flavonoids
231.220576.500C30H24O12Procyanidin A10.0009Anthocyanins
241.260576.500C30H24O12Procyanidin A20.0011Anthocyanins
251.284254.240C15H10O4Chrysin0.0004Flavones and Flavanols
262.600332.262C16H12O8Laricitrin0.4216Flavones and Flavanols
274.440302.279C16H14O6Homoeriodictyol0.0003Flavanones
284.560302.043C15H10O7Tricetin0.0003Flavones and Flavanols
295.098306.270C15H14O7(-)-epigallocatechin0.0005Flavonoids
305.210484.840C21H21ClO11Cyanidin 3-O-glucoside0.0111Anthocyanins
315.213484.840C21H21ClO11Idaein chloride0.0081Anthocyanins
325.310466.392C21H22O12Taxifolin O-glucoside0.0064Flavanones
335.380356.332C19H16O7Ophiopogonanone C0.2663Flavanones
345.390626.520C27H30O17Quercetin-3,4′-O-di-beta-glucopyranoside0.3593Flavones and Flavanols
355.420809.120C33H41O21Cl1Delphinidin 3-sophoroside-5-rhamnoside0.0329Anthocyanins
365.442468.840C21H21ClO10Callistephin chloride0.0005Anthocyanins
375.515528.890C23H25ClO12Malvidin 3-galactoside chloride0.0005Anthocyanins
385.572528.890C23H25ClO12Oenin chloride0.0022Anthocyanins
395.602338.700C15H11ClO7Delphinidin chloride0.0009Anthocyanins
405.680610.518C27H30O16C-hexosyl-luteolin O-hexoside0.0012Flavones and Flavanols
415.730594.518C27H30O15Apigenin-6,8-di-C-glycoside0.1253Flavones and Flavanols
425.745432.380C21H20O10Puerarin0.0031Isoflavonoids
435.810624.544C28H32O16di-C,C-hexosyl-methylluteolin0.1441Flavones and Flavanols
445.820594.518C27H30O15di-C,C-hexosyl-apigenin0.2993Flavones and Flavanols
455.890288.252C15H12O6Fustin0.0043Flavanones
466.030564.499C26H28O14Isoschaftoside0.0142Flavones and Flavanols
476.040594.526C27H30O15C-pentosyl-chrysoeriol O-hexoside0.0236Flavones and Flavanols
486.050564.490C26H28O14C-pentosyl-C-hexosyl-apigenin0.0028Flavones and Flavanols
496.074564.492C26H28O14Schaftoside0.0828Flavones and Flavanols
506.080430.628C27H42O4Hecogenin0.0367Flavonoids
516.090466.398C21H22O12Plantagoside0.0256Flavanones
526.100448.400C21H20O11Luteolin C-hexoside derivative0.2109Flavones and Flavanols
536.174448.380C21H20O11Isoorientin0.0972Flavones and Flavanols
546.230416.378C21H20O9Toringin0.0272Flavones and Flavanols
556.230446.121C22H22O10Sissotrin0.0007Isoflavonoids
566.250448.377C21H20O11Orientin0.0972Flavones and Flavanols
576.263322.700C15H11ClO6Cyanidin chloride0.0007Anthocyanins
586.270594.518C27H30O15Saponarin0.0360Flavones and Flavanols
596.280610.525C27H30O16Kaempferol-3-gentiobioside0.0200Flavones and Flavanols
606.280594.518C27H30O154′-O-Glucosylvitexin0.0360Flavones and Flavanols
616.300578.519C27H30O146”-O-xylosyl-glycitin0.0023Isoflavonoids
626.350611.500C27H31O16Tulipanin0.3871Anthocyanins
636.360610.520C27H30O16.xH2ORutin hydrate8.0753Flavones and Flavanols
646.380596.542C27H32O15Neoeriocitrin0.4294Flavanones
656.390434.121C21H22O10Isohemiphloin0.0171Flavanones
666.411578.520C27H30O14Vitexin-2-O-rhaMnoside0.0026Flavones and Flavanols
676.430612.576C28H36O15Neohesperidin dihydrochalcone0.1784Chalcones and dihydrochalcones
686.430596.534C27H32O15Eriocitrin0.0007Flavanones
696.451610.518C27H30O16Rutin7.9072Flavones and Flavanols
706.460432.113C21H20O10Apigenin C-glucoside0.0009Flavones and Flavanols
716.470208.255C15H12OChalcone0.5983Chalcones and dihydrochalcones
726.510594.526C27H30O15Kaempferol-3-O-rutinoside0.0309Flavones and Flavanols
736.530462.366C21H18O12Luteolin-7-O-beta-D-glucuronide0.0017Flavones and Flavanols
746.530464.382C21H20O12Quercetin-3′-O-glucoside9.1850Flavones and Flavanols
756.530464.469C23H28O10Isomucronulatol-7-O-glucoside3.3727Isoflavonoids
766.533432.378C21H20O10Isovitexin0.0007Flavones and Flavanols
776.540464.376C21H20O12Quercetin-O-glucoside0.4630Flavones and Flavanols
786.547464.380C21H20O12Myricitrin4.7113Flavones and Flavanols
796.550594.159C27H30O15Kaempferol 3-O-robinobioside0.4242Flavones and Flavanols
806.554464.380C21H20O12Hyperoside2.9062Flavones and Flavanols
816.559432.380C21H20O10Vitexin0.0006Flavones and Flavanols
826.581446.404C22H22O10Calycosin-7-O-beta-D-glucoside0.0027Isoflavonoids
836.590464.419C22H24O11Hesperetin 5-O-glucoside1.6133Flavanones
846.590464.096C21H20O12Spiraeoside7.5218Flavones and Flavanols
856.590464.096C21H20O12Isotrifoliin7.3683Flavones and Flavanols
866.590462.360C21H18O12Scutellarin0.0010Flavones and Flavanols
876.596464.380C21H20O12Isoquercitrin8.8025Flavones and Flavanols
886.620448.101C21H20O11Trifolin0.1696Flavones and Flavanols
896.620448.383C21H20O11Luteoloside0.1774Flavones and Flavanols
906.650448.377C21H20O11Kaempferol7-O-beta-D-glucopyranoside0.1172Flavones and Flavanols
916.664448.380C21H20O11Luteolin 7-O-glucoside0.1331Flavones and Flavanols
926.680432.380C21H20O10Apigenin 5-O-glucoside0.0666Flavones and Flavanols
936.720462.404C22H22O11Chrysoeriol C-hexoside0.0445Flavones and Flavanols
946.730594.526C27H30O15Lonicerin1.4742Flavones and Flavanols
956.780625.560C28H33O16Petunidin 3-O-rutinoside0.0030Anthocyanins
966.780432.380C21H20O10Genistin0.0018Isoflavonoids
976.790624.552C28H32O16Isorhamnetin-3-O-neohespeidoside6.5757Flavones and Flavanols
986.825624.544C28H32O16Narcissoside1.5707Flavones and Flavanols
996.837580.535C27H32O14Narirutin0.0171Flavanones
1006.840578.520C27H30O14Isorhoifolin0.1097Flavones and Flavanols
1016.860462.410C22H22O11Pratensein-7-O-glucoside0.1006Isoflavonoids
1026.864462.400C22H22O11Tectoridin0.0013Isoflavonoids
1036.880316.262C16H12O7Rhamnetin0.0394Flavones and Flavanols
1046.885304.250C15H12O7Taxifolin0.2520Flavones and Flavanols
1056.900268.269C16H12O4Tectochrysin0.0005Flavones and Flavanols
1066.910306.700C15H11ClO5Pelargonidin chloride0.0008Anthocyanins
1076.940608.545C28H32O15Chrysoeriol 7-O-rutinoside0.0021Flavones and Flavanols
1086.940578.520C27H30O14Rhoifolin0.2416Flavones and Flavanols
1096.970270.241C15H10O56,7,4′-Trihydroxyisoflavone0.0012Isoflavonoids
1106.970448.383C21H20O11Vincetoxicoside B0.0033Flavones and Flavanols
1116.979580.530C27H32O14Naringin0.0110Flavanones
1126.980418.390C21H22O9Liquiritin0.0054Flavanones
1137.010502.200C26H30O10Phellodensin F0.0034Flavanones
1147.020434.121C21H22O10Prunin0.0868Flavanones
1157.038432.380C21H20O10Sophoricoside0.0075Isoflavonoids
1167.060272.069C15H12O5Pinobanksin0.1659Flavanones
1177.080446.367C21H18O11Apigenin7-O-beta-D-glucuronide0.0006Flavones and Flavanols
1187.080418.351C20H18O10Kaempferol 3-A-L-Arabinopyranoside0.0060Flavones and Flavanols
1197.080432.420C22H24O9Heptamethoxyflavone0.0076Flavones and Flavanols
1207.080434.400C21H20O10Resokaempferol 7-O-hexoside0.0077Flavones and Flavanols
1217.120608.545C28H32O15Neodiosmin0.0006Flavones and Flavanols
1227.120536.000C24H24O14Eriodictyol O-malonylhexoside0.0030Flavanones
1237.180462.404C22H22O11Chrysoeriol 5-O-hexoside0.0047Flavones and Flavanols
1247.186462.403C22H22O11Homoplantaginin0.0058Flavones and Flavanols
1257.190480.376C21H20O13Myricetin 3-O-galactoside0.0185Flavones and Flavanols
1267.190492.430C23H24O12Tricin 5-O-hexoside0.0017Flavones and Flavanols
1277.200610.560C28H34O15Neohesperidin0.0461Flavanones
1287.200448.400C22H22O11Chrysoeriol 7-O-hexoside0.0087Flavones and Flavanols
1297.240448.380C21H20O11Quercitrin0.0074Flavones and Flavanols
1307.240436.410C21H24O10Phlorizin0.0718Chalcones and dihydrochalcones
1317.300476.430C23H24O11Methylchrysoeriol C-hexoside0.0030Flavones and Flavanols
1327.320526.490C27H26O11Tricin 4′-O-(beta-guaiacylglyceryl) ether0.0316Flavones and Flavanols
1337.340318.240C15H10O8Myricetin0.0088Flavones and Flavanols
1347.350432.106C21H20O10Kaempferin0.0009Flavones and Flavanols
1357.360432.106C21H20O10Kaempferol 7-O-rhamnoside0.0007Flavones and Flavanols
1367.372582.550C27H34O14Naringin dihydrochalcone0.0001Flavanones
1377.400688.639C33H36O16Tricin 4′-O-(β-guaiacylglyceryl) ether O-hexoside0.0165Flavones and Flavanols
1387.417286.240C15H10O6Fisetin0.0190Flavones and Flavanols
1397.471418.394C21H22O9Isoliquiritin0.0068Chalcones and dihydrochalcones
1407.500330.289C17H14O7Tricin0.1054Flavones and Flavanols
1417.500578.470C26H26O15Tricin O-malonylhexoside0.0295Flavones and Flavanols
1427.510688.630C33H36O16Tricin 4′-O-(beta-guaiacylglyceryl) ether 5-O-hexoside0.0137Flavones and Flavanols
1437.523436.409C21H24O10Trilobatin0.0356Chalcones and dihydrochalcones
1447.575446.360C21H18O11Baicalin0.0095Flavones and Flavanols
1457.635286.236C15H10O6Scutellarein0.0022Flavones and Flavanols
1467.660314.289C17H14O6Kumatakenin0.0134Flavones and Flavanols
1477.660254.240C15H10O44′,7-Dihydroxyflavone0.0164Flavones and Flavanols
1487.670534.420C24H22O14Tricin 5-O-hexoside derivative0.0073Flavones and Flavanols
1497.790592.553C28H32O14Linarin0.0019Flavones and Flavanols
1507.860622.571C29H34O15Pectolinarin0.0015Flavones and Flavanols
1517.879594.520C30H26O13Tiliroside0.0020Flavones and Flavanols
1527.971416.000C21H20O9Apigenin 4-O-rhamnoside0.0002Flavones and Flavanols
1537.999288.252C15H12O6Eriodictyol0.3773Flavanones
1548.020286.048C15H10O62′-Hydroxygenistein0.0155Isoflavonoids
1558.049594.561C28H34O14Poncirin0.0011Flavanones
1568.050302.043C15H10O7Morin1.3804Flavones and Flavanols
1578.060286.240C15H10O6Luteolin0.0010Flavones and Flavanols
1588.100668.600C33H32O15Tricin O-sinapoylpentoside0.0003Flavones and Flavanols
1598.180284.263C16H12O5Calycosin0.0329Isoflavonoids
1608.229314.246C16H10O7Wedelolactone0.0004Isoflavonoids
1618.260460.388C22H20O11Wogonoside0.0027Flavones and Flavanols
1628.518272.253C15H12O5Naringenin chalcone5.6733Chalcones and dihydrochalcones
1638.519500.840C21H21ClO12Myrtillin chloride0.0002Anthocyanins
1648.598274.270C15H14O5Phloretin0.2532Chalcones and dihydrochalcones
1658.610272.069C15H12O5Butin4.9779Flavanones
1668.645270.280C16H14O4Echinatin0.0001Chalcones and dihydrochalcones
1678.683272.250C15H12O5Naringenin5.7225Flavanones
1688.700270.240C15H10O5Apigenin0.0057Flavones and Flavanols
1698.720270.240C15H10O5Genistein0.0002Isoflavonoids
1708.800302.327C17H18O5Isomucronulatol0.0010Isoflavonoids
1718.811286.240C15H10O6Kaempferol0.0106Flavones and Flavanols
1728.849300.263C16H12O6Tectorigenin0.0009Isoflavonoids
1738.860302.079C16H14O67-O-Methyleriodictyol0.0017Flavanones
1748.911300.260C16H12O6Diosmetin0.0031Flavones and Flavanols
1758.960302.236C15H10O7Quercetin0.0197Flavones and Flavanols
1768.969316.262C16H12O7Isorhamnetin0.0097Flavones and Flavanols
1778.972302.270C16H14O6Hesperetin0.0073Flavanones
1789.020330.074C17H14O73,7-Di-O-methylquercetin0.0008Flavones and Flavanols
1799.160360.320C18H16O85,7,3′-trihydroxy-6,4′,5′-trimethoxyflavone0.0000Flavones and Flavanols
1809.190330.100C17H14O7Di-O-methylquercetin1.5690Flavones and Flavanols
1819.370372.375C20H20O7Isosinensetin0.0001Flavones and Flavanols
1829.550372.370C20H20O7Sinensetin0.0002Flavones and Flavanols
1839.590338.360C20H18O5Wighteone0.0004Isoflavonoids
1849.594300.263C16H12O6Hydroxygenkwanin0.6367Flavones and Flavanols
1859.870284.263C16H12O5Maackiain0.0168Isoflavonoids
1869.935300.310C17H16O5Farrerol0.0002Flavanones
18710.004344.320C18H16O7Eupatilin0.0001Flavones and Flavanols
18810.110284.225C15H8O6Rhein0.0004Anthocyanins
18910.287284.260C16H12O5Wogonin0.0014Flavones and Flavanols
19010.315286.279C16H14O5Isosakuranetin0.0023Flavanones
19110.340374.347C19H18O8Chrysosplenetin B0.0001Flavones and Flavanols
19210.372256.250C15H12O4Pinocembrin0.0015Flavanones
19310.373514.520C27H30O10Baohuoside I0.0004Flavones and Flavanols
19410.374374.341C19H18O8Casticin0.0005Flavones and Flavanols
19510.400286.328C17H18O4Loureirin A0.0010Chalcones and dihydrochalcones
19610.518402.390C21H22O8Nobiletin0.0046Flavones and Flavanols
19710.520356.332C19H16O76-Formyl-isoophiopogonanone A0.0022Flavanones
19810.550284.263C16H12O5Oroxylin A0.0005Flavones and Flavanols
19910.780314.295C17H14O6Pectolinarigenin0.0002Flavones and Flavanols
20011.410372.370C20H20O7Tangeretin0.0030Flavones and Flavanols
20111.419336.720C16H13ClO6Peonidin chloride0.0007Anthocyanins
20211.520388.368C20H20O8Demethylnobiletin0.0001Flavones and Flavanols
20311.564224.250C15H12O2Flavanone0.0007Flavanones
20411.740298.295C17H14O5Mosloflavone0.0009Flavones and Flavanols
20511.930324.370C20H20O4Isobavachalcone0.0005Chalcones and dihydrochalcones
20612.143394.420C23H22O6Deguelin0.0001Isoflavonoids
20712.670368.380C21H20O6Anhydroicaritin0.0000Flavones and Flavanols
Flavonoids compounds identified in EUMF by LC-MS.

Dyskinesia Rehabilitation Effects of Eucommia ulmoides Olive Male Flower in Zebrafish Larvae

Behavioral tests were performed on the zebrafish larvae at 6 dpf. As shown in Figure 2A, The black lines, green lines, and red lines indicate slow, medium, and fast movements, respectively. We found that the distance traveled by zebrafish in the AD model group was significantly shorter than the zebrafish in the untreated group, whether in light or dark environments (Figure 2B). The speed change of the zebrafish in the AD model group was also notably weakened after light stimulus alteration compared with the zebrafish in the untreated group (Figure 2C). These results indicated that AlCl3 lessened the locomotor capacity of the zebrafish, and this was consistent with the previous study (Pan et al., 2019; Li et al., 2020). Accordingly, the establishment of zebrafish AD model was successful. After treatment with 4.0 μM donepezil, the distance traveled and speed change of the zebrafish both increased compared with the zebrafish in the AD group (Figures 2B,C). This implied that donepezil improved the dyskinesia of zebrafish induced by AlCl3. Interestingly, a similar trend of behavioral change in the positive group was also observed in the EUMF treatment groups. When the zebrafish were co-treated with AlCl3 and different concentrations of the EUMF (50, 100, and 200 μg/mL), their dyskinesias were also reduced. In particular, the EUMF treatment correlated with a longer distance in dark environments than that of the donepezil group (Figures 2B,C). The above results indicated that the EUMF improved the exercise capacity and may play a protective role against AlCl3-induced AD-like symptoms in zebrafish.
FIGURE 2

Effect of EUMF on AlCl3-induced locomotion impairments in zebrafish. (A) Dgital track map. The red, green, and black lines depict fast, medium, and slow movements, respectively (n = 10). (B) Total distance moved in the Ctl, AlCl3, and AlCl3 + EUMF groups (***P < 0.001 vs. Ctl; ###P < 0.001 vs. AlCl3; n = 10). (C) Speed change in the Ctl, AlCl3, and AlCl3 + EUMF groups (the speed change after light stimulus is demarcated by the frame; n = 10).

Effect of EUMF on AlCl3-induced locomotion impairments in zebrafish. (A) Dgital track map. The red, green, and black lines depict fast, medium, and slow movements, respectively (n = 10). (B) Total distance moved in the Ctl, AlCl3, and AlCl3 + EUMF groups (***P < 0.001 vs. Ctl; ###P < 0.001 vs. AlCl3; n = 10). (C) Speed change in the Ctl, AlCl3, and AlCl3 + EUMF groups (the speed change after light stimulus is demarcated by the frame; n = 10).

Inhibition the Amyloid β-Protein Aggregation Effects of Eucommia ulmoides Olive Male Flower in the Zebrafish Larvae

Amyloid β-protein deposition is an important clinical hallmark in AD patients (Meldolesi, 2017). To further identify the anti-AD activity of the EUMF, the Aβ plaques in the heads of zebrafish were quantitatively determined. As shown in Figure 3, only a few of the Aβ plaques were observed in the brain of the untreated group. In contrast, there were many large Aβ plaques in the brain of the AD model group. Compared with the AD group, larval treatment with donepezil or EUMF (50, 100, and 200 μg/mL) significantly reduced the Aβ plaque count. These results implied that EUMF had anti-AD activity.
FIGURE 3

Inhibition of EUMF on Aβ aggregation in zebrafish. (A) The Aβ plaques in the brain region were stained using thioflavin S in the Ctl, AlCl3, and AlCl3 + EUMF groups (Aβ is demarcated by arrows; scale bar = 100 μm). (B) Statistical analysis of the Aβ plaque count in each group (***P < 0.001 vs. Ctl; #P < 0.05; ###P < 0.001 vs. AlCl3; n = 10).

Inhibition of EUMF on Aβ aggregation in zebrafish. (A) The Aβ plaques in the brain region were stained using thioflavin S in the Ctl, AlCl3, and AlCl3 + EUMF groups (Aβ is demarcated by arrows; scale bar = 100 μm). (B) Statistical analysis of the Aβ plaque count in each group (***P < 0.001 vs. Ctl; #P < 0.05; ###P < 0.001 vs. AlCl3; n = 10).

Inhibitory Activity of Eucommia ulmoides Olive Male Flower on the Ache Activity

Ache is an enzyme that can degrade ACh. Many studies have proposed that a reduced level of ACh may be the primary etiology of AD. Hence, Ache has also been proposed to be related to the formation of AD (Remya et al., 2013; Hu et al., 2019). Based on this, we assessed the activity of Ache to explore the protective mechanism of EUMF on AD. As shown in Figure 4, the AD model group showed a higher activity of Ache compared with the untreated group. However, the groups co-treated with both AlCl3 and donepezil or different concentrations of EUMF showed reduced activity of Ache compared with the AD model group. Our results indicated that the EUMF may be an effective therapeutic agent for AD by suppressing the activity of Ache.
FIGURE 4

Inhibition of EUMF on the AChE activity in zebrafish (***P < 0.001 vs. Ctl; #P < 0.05, ##P < 0.01, ###P < 0.001 vs. AlCl3; n = 10).

Inhibition of EUMF on the AChE activity in zebrafish (***P < 0.001 vs. Ctl; #P < 0.05, ##P < 0.01, ###P < 0.001 vs. AlCl3; n = 10).

Effect of Eucommia ulmoides Olive Male Flower on AlCl3-Induced Apoptosis in the Brain

We found many apoptotic cells that appeared primarily in the brain region in the zebrafish AD model. In contrast, no obvious apoptotic cells were observed in the control group. Donepezil or different concentrations of the EUMF treatment significantly reduced the number of apoptotic cells in the zebrafish brains (Figure 5). The above results suggested that EUMF suppressed the apoptosis induced by AlCl3 in zebrafish brain.
FIGURE 5

Effect of EUMF on apoptosis in the brains of the AlCl3-modeled zebrafish. (A) The apoptotic cells were stained with TUNEL (scale bar = 100 μm). (B) Statistical analysis of the apoptotic cells count in the larvae heads (***P < 0.001 vs. Ctl; ###P < 0.001 vs. AlCl3; n = 10).

Effect of EUMF on apoptosis in the brains of the AlCl3-modeled zebrafish. (A) The apoptotic cells were stained with TUNEL (scale bar = 100 μm). (B) Statistical analysis of the apoptotic cells count in the larvae heads (***P < 0.001 vs. Ctl; ###P < 0.001 vs. AlCl3; n = 10).

Effect of Eucommia ulmoides Olive Male Flower on the Expression of Autophagy-Related and Neurotransmitter-Related Genes

Many lines of evidence have suggested that dysregulated autophagy is implicated in a pathogenic role in the neurological diseases (Sheng et al., 2010; Chu, 2018). Therefore, we assayed the expression of autophagy-related genes to investigate whether EUMF protected against AD-like symptoms by regulating autophagy. Ambra1a, atg5, ulk1b, and lc3b are core members involved in autophagy (Kang et al., 2011; Jiang et al., 2013). We found that transcript levels of aforementioned genes were significantly upregulated in the AD model group compared with the control, while when the EUMF reached a certain concentration, it reversed the increases (Figure 6). In addition, we also found that the EUMF treatment under a certain concentration downregulated the expression level of ache and slc6a3, and these were drastically increased after treatment with AlCl3 (Figure 6).
FIGURE 6

Transcriptional alterations of genes. The amount of gene expression was exhibited as the relative expression (shown as fold) compared with the Ctl. (**P < 0.01, ***P < 0.001 vs. Ctl; #P < 0.05, ###P < 0.001 vs. AlCl3). (A–D) Expressions of genes involved in autophagy. (E) Transcript levels of ache. (F) Transcript levels of slc6a3.

Transcriptional alterations of genes. The amount of gene expression was exhibited as the relative expression (shown as fold) compared with the Ctl. (**P < 0.01, ***P < 0.001 vs. Ctl; #P < 0.05, ###P < 0.001 vs. AlCl3). (A–D) Expressions of genes involved in autophagy. (E) Transcript levels of ache. (F) Transcript levels of slc6a3.

Discussion

Alzheimer’s disease is the most common clinical degenerative disease associated with aging. The complex pathogenetic factors of AD have limited its effective treatment. EUO is a traditional Chinese medicine. It has been reported that the extracts of EUO leaf can be used to treat AD. Therefore, we investigated the therapeutic effects of its male flowers on AD like symptoms using zebrafish. We found that the dyskinesia in the zebrafish AD model was significantly improved by EUMF. The Aβ plaques count, Ache activity, and number of apoptotic cells in the zebrafish AD model were also clearly reduced by EUMF. The above results indicated that the EUMF may be an agent for AD treatment. In addition, mechanism investigation revealed that the anti-AD activity of the EUMF may be related to its inhibition of excessive autophagy and abnormal expressions of ache and slc6a3 genes. Autophagy is an important biological process by which cellular material is degraded by lysosomes or vacuoles and recycled. Paradoxically, it has the characteristics of a double-edged sword. Autophagy can serve to protect the nervous system by clearing degrading damaged organelles or accumulated misfolded proteins in neurons, but it may also induce neuron death and damage the nervous system (Shintani and Klionsky, 2004). Previous studies have shown that autophagy influences the secretion of Aβ to the extracellular space in neurons through either excretory or exocytic mechanisms, and hence it plays a critical role in Aβ plaque formation. Furthermore, extracellular Aβ plaques accumulation is an important pathogenic factor leading to AD (Nilsson et al., 2015). Based on these facts, we hypothesized that AlCl3 may activate abnormal excessive autophagy by upregulating the expression of ambra1a, atg5, ulk1b, and lc3b in zebrafish. Then further damage, referring to the deposition of extracellular Aβ plaques induced by abnormal excessive autophagy, would occur. Finally, AD-like symptoms in the zebrafish were induced. However, EUMF restored high expressions of ambra1a, atg5, ulk1b, and lc3b induced by AlCl3. Thus, autophagy was not excessively activated. Accordingly, this reduced the extracellular Aβ plaque count and reversed AD’s disease-like pathology in zebrafish. Ache is the gene that encode Ache that inactivates the neurotransmitter ACh by catalyzing its hydrolysis to choline and acetic acid (Hu et al., 2019). Slc6a3 is the gene that encode the dopamine transporter (Dat) that can provide rapid clearance of dopamine (DA) (Dedic et al., 2018). The primary function of ACh is to complete the transmission of neural signals. Once the synthesis and decomposition of ACh is abnormal, neural signaling transition may be blocked. To some extent, AD will be the result (Hu et al., 2019). DA is also a neurotransmitter that is critically implicated in cognitive function. Previous studies have found that the restoration of DA transmission plays a role in learning and memory in the mouse model of AD. DA dysfunction has a pathogenic role in the cognitive decline symptoms of AD (Martorana and Koch, 2014). Because Ache and Dat are inhibitors of ACh and DA, respectively, it is conceivable that they also play a critical role in the occurrence of AD. Interestingly, our results showed that both the expressions of ache and slc6a3 genes were upregulated in the AD zebrafish model. However, treatment with EUMF reduced these increased expressions. Collectively, we suggest that beside of inhibiting the abnormal excessive autophagy, EUMF also reverse AD-like pathology in zebrafish by regulating the expressions of ache and slc6a3 at the transcript levels. Definitely, we will perform gene expression test of other neurotransmitters including glutamate in the future to further investigate the underlying mechanism. Flavonoids are a group of plant metabolites which can improve the cognitive functions. They can work within the processes associated with AD (Kaur et al., 2022; Maccioni et al., 2022). For example, quercetin belonging to the subcategory of flavonoids can significantly mitigate memory deficits in scopolamine mice model via protection against neuroinflammation and neurodegeneration (Olayinka et al., 2022). Eriodictyol which is a natural flavonoid compound can ameliorate cognitive dysfunction in APP/PS1 mice by inhibiting ferroptosis (Li L. et al., 2022). Anthocyanins can reduce the neuronal damage in in vivo and in vitro models of AD (Li H. et al., 2022). Here, we identified many flavonoids including quercetin-3′-O-glucoside, isoquercitrin, rutin hydrate, rutin, spiraeoside, isotrifoliin, isorhamnetin-3′-O-neohespeidoside, naringenin, naringenin chalcone, butin, myricitrin, isomucronulatol-7-O-glucoside, hyperoside, hesperetin 5-O-glucoside, narcissoside, di-O-methylquercetin, lonicerin, and morin in EUMF. Therefore, flavonoids in EUMF may contribute to its anti-AD effects. However, one limitation of this study is that the exact compounds of flavonoids in EUMF, which act as a promising agent against AD need further investigation. In the further work, we will analyze the composition and activity of the flavonoid compounds in EUMF to thoroughly understand the anti-AD activity of EUMF.

Conclusion

In conclusion, our study provided evidence that EUMF had anti-AD activity. EUMF ameliorated AD-like pathology in zebrafish possibly by inhibiting excessive autophagy and the abnormal expressions of ache and slc6a3. Flavonoid compounds in the EUMF may contribute to this biological process (Figure 7). Our data implied that EUMF is an attractive therapeutic candidate for AD.
FIGURE 7

The proposed mechanism underlying the anti-AD effect of EUMF. EUMF inhibits the excessive autophagy and abnormal expressions of the ache and slc6a3 genes to exert the therapeutic effects against AD-like symptoms. Flavonoids in EUMF may contribute to this biological process.

The proposed mechanism underlying the anti-AD effect of EUMF. EUMF inhibits the excessive autophagy and abnormal expressions of the ache and slc6a3 genes to exert the therapeutic effects against AD-like symptoms. Flavonoids in EUMF may contribute to this biological process.

Data Availability Statement

The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.

Ethics Statement

The animal study was reviewed and approved by the Animal Ethics Committe of Biology Institute, Shandong Academy of Sciences.

Author Contributions

MJ conceptualized the idea and supervised the entire study. CS, SZ, SB, and JD performed the study and analyzed the results. MJ, QR, and YZ analyzed the results. CS and SZ wrote the manuscript. MJ and KL revised the manuscript and contributed to the final form. All authors read and approved the final manuscript.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
  38 in total

1.  Linarin improves the dyskinesia recovery in Alzheimer's disease zebrafish by inhibiting the acetylcholinesterase activity.

Authors:  Hongye Pan; Jinghui Zhang; Yangyang Wang; Keke Cui; Yueting Cao; Longhu Wang; Yongjiang Wu
Journal:  Life Sci       Date:  2019-02-22       Impact factor: 5.037

Review 2.  Alzheimer mechanisms and therapeutic strategies.

Authors:  Yadong Huang; Lennart Mucke
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

Review 3.  Alzheimer's disease due to loss of function: A new synthesis of the available data.

Authors:  Kasper P Kepp
Journal:  Prog Neurobiol       Date:  2016-06-18       Impact factor: 11.685

4.  A map of cis-regulatory elements and 3D genome structures in zebrafish.

Authors:  Hongbo Yang; Yu Luan; Tingting Liu; Hyung Joo Lee; Li Fang; Yanli Wang; Xiaotao Wang; Bo Zhang; Qiushi Jin; Khai Chung Ang; Xiaoyun Xing; Juan Wang; Jie Xu; Fan Song; Iyyanki Sriranga; Chachrit Khunsriraksakul; Tarik Salameh; Daofeng Li; Mayank N K Choudhary; Jacek Topczewski; Kai Wang; Glenn S Gerhard; Ross C Hardison; Ting Wang; Keith C Cheng; Feng Yue
Journal:  Nature       Date:  2020-11-25       Impact factor: 49.962

5.  Autophagy activation is associated with neuroprotection in a rat model of focal cerebral ischemic preconditioning.

Authors:  Rui Sheng; Li-Sha Zhang; Rong Han; Xiao-Qian Liu; Bo Gao; Zheng-Hong Qin
Journal:  Autophagy       Date:  2010-05-16       Impact factor: 16.016

6.  Quercetin mitigates memory deficits in scopolamine mice model via protection against neuroinflammation and neurodegeneration.

Authors:  Juliet Olayinka; Anthony Eduviere; Olusegun Adeoluwa; Adedamola Fafure; Adeshina Adebanjo; Raymond Ozolua
Journal:  Life Sci       Date:  2022-01-12       Impact factor: 5.037

7.  Anthocyanin-rich blueberry extracts and anthocyanin metabolite protocatechuic acid promote autophagy-lysosomal pathway and alleviate neurons damage in in vivo and in vitro models of Alzheimer's disease.

Authors:  Hui Li; Tingting Zheng; Fuzhi Lian; Tong Xu; Wenya Yin; Yugang Jiang
Journal:  Nutrition       Date:  2021-08-31       Impact factor: 4.008

8.  Curcumin ameliorates the neurodegenerative pathology in A53T α-synuclein cell model of Parkinson's disease through the downregulation of mTOR/p70S6K signaling and the recovery of macroautophagy.

Authors:  Tian-Fang Jiang; Ying-Jie Zhang; Hai-Yan Zhou; Hong-Mei Wang; Li-Peng Tian; Jun Liu; Jian-Qing Ding; Sheng-Di Chen
Journal:  J Neuroimmune Pharmacol       Date:  2013-01-17       Impact factor: 4.147

Review 9.  Potential of flavonoids as anti-Alzheimer's agents: bench to bedside.

Authors:  Rajwinder Kaur; Ankita Sood; Damanpreet Kaur Lang; Tapan Behl; Saurabh Bhatia; Ahmed Al-Harrasi; Lotfi Aleya
Journal:  Environ Sci Pollut Res Int       Date:  2022-01-24       Impact factor: 4.223

Review 10.  Flavonoid-Based Nanomedicines in Alzheimer's Disease Therapeutics: Promises Made, a Long Way To Go.

Authors:  Pragya Prasanna; Arun Upadhyay
Journal:  ACS Pharmacol Transl Sci       Date:  2021-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.